The expression of EMMPRIN, VEGFR-2 and HIF-2α was also evaluated by immunohistochemical analysis of tumors obtained from 5 of these melanoma patients chosen on the basis of their EMMPRIN expression as determined by the qRT-PCR measurements. This evidence concerns the gene EPAS1 and melanoma.